Clinical trial
Intensive Dose Tinzaparin in Hospitalized COVID19 Patients
NCT05036824 is registered in ClinicalTrials.gov with University Hospital of Patras as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intensive Dose Tinzaparin in Hospitalized COVID19 Patients
- Lead sponsor
- University Hospital of Patras
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- April 30, 2022
- Enrollment
- 300 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, hospitalization